DELRAY BEACH, Fla., Sept. 5, 2025 /PRNewswire/ -- The report "Medical Polymer Market by Type (Medical Plastics, Medical Elastomers), Application (Medical Disposables, Medical Instruments and Devices, Prosthetics, Diagnostics Instruments and Tools), Manufacturing Technology, and Region - Global Forecast to 2030", medical polymer market is projected to reach USD 66.29 billion by 2030 from USD 44.70 billion in 2025, at a CAGR of 8.2% during the forecast period.
Browse in-depth TOC on "Medical Polymer Market"
357 - Tables
54 - Figures
450 - Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=211635984
Various factors affect the medical polymer market, and it is important to note that they are an indication of advances in the healthcare, materials science, and patient care fields. There is a growing demand for lightweight, durable, and biocompatible materials for medical devices, production of everything from implants to surgical instruments to diagnostic tools. The growing global elderly population as well as increased incidences in chronic diseases, are leading to exponential requirements for fast and safe medical solutions, translating to increased demand for high-performance polymers. The advancement of healthcare infrastructure in emerging economies is fostering increased use of medical polymers in medical disposables and drug delivery systems. Technological advancements, including bioresorbable polymers and antimicrobial polymers and enhancement of the use of medical polymers are enabling implementation in a variety of medical applications. Due to challenges regarding regulatory standards and the need to create safer materials, the industry will continue to experience ongoing research & development.
Medical plastics is projected to account for the largest share of the medical polymer market during the forecast period
The medical plastics segment is projected to be the largest in the medical polymer industry due to their affordability, versatility, and extensive use throughout the medical industry in medical devices. Medical plastics are biocompatible, chemically resistant, and able to withstand sterilization processes, and, therefore enable manufacturers to create syringes, catheters, IV bags, surgical equipment and devices, and analytical and diagnostic devices. Medical plastics are lightweight, can be molded into various shapes and forms, can be manufactured into complex designs and forms, and are rigid yet safe for patients. The healthcare profession is continuing to call for the adoption of single-use and disposable medical devices to reduce cross-contamination and healthcare-associated infections (HCAIs) in hospitals; therefore, the demand for medical plastics will continue to grow. Plastics are evolving through continued developments in polymer formulations, such as antimicrobial or bioresorbable plastics, which significantly increase functionality. In terms of functionality, usability, and compliance with healthcare regulations, medical plastics are taking the lead as the most common type of products within the medical polymer business.
Medical instruments & devices is projected to be the fastest-growing application in the medical polymer market during forecast period
Medical instruments & devices is the fastest-growing and largest application segment of the medical polymer market due to the increased demand for advanced, disposable, medical tools that are minimally invasive. The growing global burden of chronic disease, aging populations, and the rise in surgical procedures are contributing to the demand for reliable, high performing devices made of biocompatible polymers which have superior properties, including flexibility, strength, chemical resistance, and sterilization capabilities and increasingly used in surgical instruments, catheters, implants, diagnostics, and monitoring equipment. A heightened emphasis on patient safety and infection control has driven the increased clinical usage of single-use, polymer-based devices. The continual advancements in polymer technology, such as further developments in bioresorbable and antimicrobial polymers are also increasing device effectiveness. All these factors strengthen medical instruments and devices as the leading application segment of the medical polymer market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=211635984
Injection molding manufacturing technology to be the fastest-growing in the medical polymer market during the forecast period
Injection molding is taking over the medical polymer market as the fastest-growing manufacturing technology largely due to its fast-paced production of expertly accurate and elaborate to simple and consistent components, uniform to large quantities, and low costs. Injection-molded items are found in a variety of medical products, including syringes, surgical implements or devices, housings, and diagnostic approaches. The injection-molding method can be automated and expedited, all while rigorously adhering to hygiene and stringent quality controls, which are highly critically evaluated in the healthcare industry. As demand for disposable and miniaturized medical devices increases, injection molding offers scalability, meaning it can be ramped up to cost-effectively produce in quantities with efficiency. The advancement of multilayered and micro-injection molded medical products has bolstered injection molding to continue to be the best option for the mass production of medical polymer devices.
Europe to be the second-largest region in the medical polymer market during the forecast period
Europe is the second-largest market within the medical polymer space because of its sophisticated healthcare infrastructure, established regulatory environment, and high demand for innovative technologies for medical devices and disposables. Active marketplaces in Europe comprise some of the very best medical device manufacturers and research facilities, which drives the pursuit of high-performance polymers in medical use. Increased spending on healthcare, rising aging population, and high incidences of chronic disease are supporting strong demand for disposable medical devices. The regulations set by the European Medicines Agency (EMA) and European Medical Device Regulations require the highest level of safety and quality for healthcare products, which creates demand for biocompatible and specialized polymers for medical use, discarding medical devices that may be harmful to patients. Sustainability initiatives throughout Europe and the consideration of safe and environmentally sustainable medical products also drives the expansion of recyclable polymer materials and biodegradable polymer materials.
Request Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=211635984
Key Players
The Medical Polymer Market report includes key manufacturers such as BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese corporation (US), Evonik Industries (Germany), Arkema (France), Solvay (Belgium), Kuraray Co., Ltd. (Japan), Momentive Performance Materials Inc. (US), and DuPont (US), among others.
Get access to the latest updates on Medical Polymer Companies and Medical Polymer Market Size
Browse Adjacent Market: Resins & Polymers Market Research Reports & Consulting
Related Reports:
Medical Elastomer Market - Global Forecast to 2029
Polycarbonate Resin Market - Global Forecast to 2029
Meta-aramid Fiber Market - Global Forecast to 2027
Flexible Elastomeric Foam Market - Global Forecast to 2029
Antimicrobial Plastics Market - Global Forecast to 2028
About MarketsandMarkets
MarketsandMarkets has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/medical-polymer-market-worth-66-29-billion-by-2030---exclusive-report-by-marketsandmarkets-302547572.html
